A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa

NCT07077902 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Hidradenitis Suppurativa

Interventions

DRUG: Topical roflumilast 0.3% foam

Sponsor

Tulane University

Collaborators

[object Object]